Singapore – Recently, Shanghai Microport MedBot (Group) Co.,Ltd. (hereinafter referred to as "MicroPort® MedBot®"), a subsidiary of NDR Medical Technology Private Limited (hereinafter referred to as "NDR"), announced that its product, the Auto Needle Targeting system (hereinafter referred to as "ant-x™ percutaneous intervention robot"), has obtained FDA certification, making it the world's first FDA-certified C-arm guided percutaneous nephrolithotomy (PCNL) robot device. Previously, ant-x™ had obtained CE certification in 2020. 

 As the first integrated C-arm imaging and AI software intervention robot launched by NDR, the ant-x™ percutaneous intervention robot aims to assist doctors in achieving safe and accurate percutaneous puncture and needle placement for percutaneous nephrolithotomy. Precise puncture positioning is a crucial step in percutaneous nephrolithotomy, and the ant-x™ percutaneous intervention robot fully automates the processes of system calibration and needle placement calibration. This reduces the difficulty of the operation, shortens the learning curve for doctors, improves the accuracy of puncture, and reduces surgical complications. It is compatible with all types of C-arm machines and can be widely used in interventional surgeries that require percutaneous needle placement, such as urology, neurology, orthopedics, etc., especially in the treatment of common diseases such as herniated disc.

Mr. Liu Yu, Executive Vice President and Chief Commercial Officer of MicroPort® MedBot®, said, "With the development of technology, surgical robots have higher precision, consistency, and manipulability. Compared to traditional minimally invasive surgery, they can effectively reduce the burden on doctors, improve the success rate of surgery, reduce the size of surgical incisions, and shorten the patient's postoperative recovery period. We hope that our surgical robot products such as Tumai™, SkyWalker™(Honghu), Mona Lisa, R-ONE™, ant-x™, and others can be increasingly applied in clinical practice in the current context of continuously increasing demand for high-quality medical resources, so as to achieve the original intention to ‘Make Surgery Easier, Safer and Less Invasive’."